« Previous
Next »
Respiratory Medicine
Volume 104, Issue 12
, Pages 1929-1936
, December 2010
Behaviour and survival of high-grade neuroendocrine carcinomas of the lung
References
- . Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972;64:413–421
- . Large cell neuroendocrine tumors of the lung. Cancer. 1985;56:1624–1629
- . Neuroendocrine neoplasms of the lung: a clinicopathologic update. J Thorac Cardiovasc Surg. 1989;98:321–332
- . Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, imunohistochemical, and flow cytometry study of 35 cases. Am J Surg Pathol. 1991;15:529–553
- . Histological typing of lung and pleural tumors. 3rd ed.. Germany: Springer; 1999;
- . The 2004 WHO classification of neuroendocrine lung tumors. In: Travis WD, Brambilla E, Müller-Hermelink H, Harris CC editor. Tumors of the lung, pleura, thymus and heart. Lyon, France: IARC Press; 2004;p. 59–63
- . Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer. 2001;91:1992–2000
- . Large cell neuroendocrine carcinoma of the lung: a histologic and immunohisochemical study of 22 cases. Am J Surg Pathol. 1998;22:526–537
- . Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg. 2002;124:285–292
- . Neuroendocrine neoplasms of the lung: a prognostic.spectrum. J Clin Oncol. 2006;24:70–76
- . Large cell neuroendocrine carcinoma of the lung: a 10-year.clinicopathologic retrospective study. Ann Thorac Surg. 2004;77:1163–1167
- . Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;130:166–172
- . Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer. 2001;92:1108–1112
- . Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases. Lung Cancer. 2002;37:287–292
- . Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg. 1997;63:180–185
- . Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancer. Semin Thorac Cardiovasc Surg. 2006;18:206–210
- . Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma. J Thorac Cardiovasc Surg. 2006;132:312–315
- . Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg. 2003;75:348–352
- . Revisions in the international system for staging lung cancer. Chest. 1997;111:1710
- . Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. 1998;22:934–944
- . Reproducibility of neuroendocrine lung tumors classification. Hum Pathol. 1998;29:272–279
- . Morphometry confirms the presence of considerable nuclear size overlap between “small cells” and “large cells” in high grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol. 2001;116:463–464
- . Prognostic factors in neuroendocrine lung tumors: a Spanish multicentre study. Ann Thorac Surg. 2000;70:258–263
- . Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg. 1996;62:798–810
- . Japan Lung Cancer Research Group on postsurgical adjuvant chemotherapy with uraciltegafur for adenocarcinoma of the lung. N Engl J Med. 2004;350:1713–1721
- . Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351–360
- . Vinorelbine plus cisplatine vs. observation in resected non- small-cell lung cancer. N Engl J Med. 2005;352:2589–2597
- . Prophylactic cranial irradiation as a component of intensified initial treatment of locally advanced non-small cell lung cancer. Lung Cancer. 2003;42:S53–S56
- . Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;341:476–484
PII: S0954-6111(10)00352-5
doi: 10.1016/j.rmed.2010.08.007
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
Respiratory Medicine
Volume 104, Issue 12
, Pages 1929-1936
, December 2010
